These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5115681)

  • 21. Antitrichomonal activity of mesoionic thiazolo[3,2-a]pyridines.
    Walker KA; Sjogren EB; Matthews TR
    J Med Chem; 1985 Nov; 28(11):1673-9. PubMed ID: 4067993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Oral therapy in type 2 diabetes. Critical evaluation of glitazones].
    Lotz N
    MMW Fortschr Med; 2002 Jan; 144(3-4):48-50. PubMed ID: 11862793
    [No Abstract]   [Full Text] [Related]  

  • 23. Design and synthesis of a new class of malonyl-CoA decarboxylase inhibitors with anti-obesity and anti-diabetic activities.
    Tang H; Yan Y; Feng Z; de Jesus RK; Yang L; Levorse DA; Owens KA; Akiyama TE; Bergeron R; Castriota GA; Doebber TW; Ellsworth KP; Lassman ME; Li C; Wu MS; Zhang BB; Chapman KT; Mills SG; Berger JP; Pasternak A
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6088-92. PubMed ID: 20832306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The hypoglycemic effect of ciglitazone in obese, hyperglycemic animal models.
    Chang AY; Wyse BM
    Prog Clin Biol Res; 1988; 265():177-92. PubMed ID: 3043443
    [No Abstract]   [Full Text] [Related]  

  • 25. Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents.
    Clark DA; Goldstein SW; Volkmann RA; Eggler JF; Holland GF; Hulin B; Stevenson RW; Kreutter DK; Gibbs EM; Krupp MN
    J Med Chem; 1991 Jan; 34(1):319-25. PubMed ID: 1992133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anthelmintic quaternary salts. 3. Benzothiazolium salts.
    Garmaise DL; Paris GY; Komlossy J; Chambers CH; McCrae RC
    J Med Chem; 1969 Jan; 12(1):30-6. PubMed ID: 5763036
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypoglycemia activity and toxicity of 4-isoxazolylpyridinium salts and phenformin in normal mice.
    Blickens DA; Riggi SJ
    Toxicol Appl Pharmacol; 1969 Mar; 14(2):393-400. PubMed ID: 5772863
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antidiabetic agents and renal insufficiency].
    Robles NR; Blanco J
    Nefrologia; 2002; 22(4):325-8. PubMed ID: 12369123
    [No Abstract]   [Full Text] [Related]  

  • 29. Novel anthelmintic agents. 3. 1-(2-Arylvinyl)pyridinium salts.
    McFarland JW; Howes HL
    J Med Chem; 1969 Nov; 12(6):1079-86. PubMed ID: 5351449
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on antidiabetic agents. IV. Synthesis and activity of the metabolites of 5-[4-(1-methylcyclohexylmethoxy)benzyl]-2,4-thiazolidinedione (ciglitazone).
    Sohda T; Meguro K; Kawamatsu Y
    Chem Pharm Bull (Tokyo); 1984 Jun; 32(6):2267-78. PubMed ID: 6488400
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis and hypoglycemic activity of phenacyltriphenylphosphoranes and phosphonium salts.
    Blank B; DiTullio NW; Deviney L; Roberts JT; Saunders HL
    J Med Chem; 1975 Sep; 18(9):952-4. PubMed ID: 1159720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoglycemic activity of Buchholzia coriacea (Capparaceae) seeds in streptozotocin-induced diabetic rats and mice.
    Adisa RA; Choudhary MI; Olorunsogo OO
    Exp Toxicol Pathol; 2011 Nov; 63(7-8):619-25. PubMed ID: 20965120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Administration of troglitazone, but not pioglitazone, reduces insulin resistance caused by short-term dexamethasone (DXM) treatment by accelerating the metabolism of DXM.
    Morita H; Oki Y; Ito T; Ohishi H; Suzuki S; Nakamura H
    Diabetes Care; 2001 Apr; 24(4):788-9. PubMed ID: 11315852
    [No Abstract]   [Full Text] [Related]  

  • 34. MK-767. Kyorin/Banyu/Merck.
    Calkin AC; Thomas MC; Cooper ME
    Curr Opin Investig Drugs; 2003 Apr; 4(4):444-8. PubMed ID: 12808885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose transport-enhancing and hypoglycemic activity of 2-methyl-2-phenoxy-3-phenylpropanoic acids.
    Sarges R; Hank RF; Blake JF; Bordner J; Bussolotti DL; Hargrove DM; Treadway JL; Gibbs EM
    J Med Chem; 1996 Nov; 39(24):4783-803. PubMed ID: 8941393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel spirosuccinimides with incorporated isoindolone and benzisothiazole 1,1-dioxide moieties as aldose reductase inhibitors and antihyperglycemic agents.
    Wrobel J; Dietrich A; Woolson SA; Millen J; McCaleb M; Harrison MC; Hohman TC; Sredy J; Sullivan D
    J Med Chem; 1992 Nov; 35(24):4613-27. PubMed ID: 1469692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. cis-1-(2-(p-anisidinomethyl)cyclohexyl)piperidine and related compounds. Oral hypoglycemic agents.
    Rynbrandt RH; Schmidt FL; Szmuszkovicz J
    J Med Chem; 1971 Oct; 14(10):985-7. PubMed ID: 5115700
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis, hypolipidemic and hypoglycemic activity of some novel 2-(4-(2-substituted aminothiazole-4-yl) phenoxy)-2-methyl propanoic acid derivatives.
    Mokale SN; Elgire RD; Sakle N; Shinde DB
    Bioorg Med Chem Lett; 2011 Jan; 21(2):682-5. PubMed ID: 21193309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
    Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
    Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New oral antidiabetic drugs. 3.
    Ambrogi V; Bloch K; Daturi S; Logemann W; Parenti MA; Tommasini R
    Arzneimittelforschung; 1972 Mar; 22(3):542-4. PubMed ID: 5067927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.